Peros G - Search Results

1

Transcriptional impairment of beta-catenin/E-cadherin complex is not associated with beta-catenin mutations in colorectal carcinomas.

Garinis GA, Spanakis NE, Menounos PG, Manolis EN, Peros G. Garinis GA, et al. Among authors: peros g. Br J Cancer. 2003 Jan 27;88(2):206-9. doi: 10.1038/sj.bjc.6600706. Br J Cancer. 2003. PMID: 12610504 Free PMC article.

2

Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.

Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP, Manolis EN, Peros G. Garinis GA, et al. Among authors: peros g. J Pathol. 2002 Dec;198(4):442-9. doi: 10.1002/path.1237. J Pathol. 2002. PMID: 12434413

3

High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas.

Garinis GA, Manolis EN, Spanakis NE, Patrinos GP, Peros G, Menounos PG. Garinis GA, et al. Among authors: peros g. J Mol Med (Berl). 2003 Apr;81(4):256-63. doi: 10.1007/s00109-003-0420-4. Epub 2003 Apr 2. J Mol Med (Berl). 2003. PMID: 12684753

4

Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.

Karamitopoulou E, Zlobec I, Koumarianou A, Patsouris ES, Peros G, Lugli A. Karamitopoulou E, et al. Among authors: peros g. Cancer. 2010 Oct 1;116(19):4474-86. doi: 10.1002/cncr.25304. Cancer. 2010. PMID: 20572035 Free article.

5

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.

Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A. Karamitopoulou E, et al. Among authors: peros g. Pathology. 2011 Feb;43(2):133-7. doi: 10.1097/PAT.0b013e3283425b7f. Pathology. 2011. PMID: 21233674

6

Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.

Zavrides H, Zizi-Sermpetzoglou A, Elemenoglou I, Papatheofanis I, Peros G, Athanasas G, Panousopoulos D. Zavrides H, et al. Among authors: peros g. Pol J Pathol. 2006;57(3):149-59. Pol J Pathol. 2006. PMID: 17219742

7

Duodeno-pancreatic neuroendocrine tumours.

Peros G, Sakorafas GH, Konstantoudakis G, Giannopoulos GA, Petropoulou K, Parasi A. Peros G, et al. Eur J Cancer Care (Engl). 2010 May;19(3):393-402. doi: 10.1111/j.1365-2354.2007.00894.x. Epub 2009 Aug 25. Eur J Cancer Care (Engl). 2010. PMID: 19708940

8

P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population.

Dakouras A, Nikiteas N, Papadakis E, Perakis M, Valis D, Rallis G, Tzanakis N, Peros G, Tsigkris C, Kittas C, Karakitsos P. Dakouras A, et al. Among authors: peros g. Anticancer Res. 2008 Mar-Apr;28(2A):1039-43. Anticancer Res. 2008. PMID: 18507052 Free article.

9

Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.

Zavrides HN, Zizi-Sermpetzoglou A, Panousopoulos D, Athanasas G, Elemenoglou I, Peros G. Zavrides HN, et al. Among authors: peros g. Folia Histochem Cytobiol. 2005;43(1):31-6. Folia Histochem Cytobiol. 2005. PMID: 15871560

10

Obstructing sigmoid cancer in a patient with a large, tender, non-reducible inguinal hernia: the obvious diagnosis is not always the correct one.

Sakorafas GH, Peros G. Sakorafas GH, et al. Among authors: peros g. Eur J Cancer Care (Engl). 2008 Jan;17(1):72-3. doi: 10.1111/j.1365-2354.2007.00811.x. Eur J Cancer Care (Engl). 2008. PMID: 18181894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters